GH Guardant Health, Inc.
$178.06▲ +2.78%
Healthcare
Other
After hours
$178.06▲ +0.00%
Oct 27, 4:53 PM ET
Volume 1.49M
Avg Volume (10D) 1.70M
Key Metrics & Fundamentals
Market Cap
$23.89B
P/E Ratio
–
Div Yield
0.00%
52W Range
68.02 - 191.05
% vs 50 MA
5.61%
% vs 200 MA
37.63%
RSI-14
59.5
MACD Histogram
+1.0300
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$69.54M
Gross Rev
$334.98M
Gross Profit
$219.03M
EBITDA
-$109.05M
COGS
$115.95M
Operating Exp
$348.15M
Operating Income
-$129.12M
EBIT
-$129.12M
Pretax Income
-$119.96M
Net Income
-$120.14M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News

3 Reasons GH is risky and 1 stock to buy instead
StockStory · Oct 26, 2026 6:30 PM ET

What Happens To Tempus AI Stock If Its Cash Burn Continues?
Trefis · Oct 26, 2026 8:47 AM ET

Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More
24/7 Wall St. · Oct 23, 2026 7:51 AM ET
Roth Capital Initiates Coverage on Guardant Health With Buy Rating, $200 Price Target
MT Newswires · Oct 23, 2026 7:26 AM ET

IBD Stock Of The Day, Natera, Hovering Near Buy Point
Investor's Business Daily · Oct 22, 2026 5:40 PM ET

Natera Partners With TransCode to Advance Colorectal Cancer Trial
Zacks · Oct 21, 2026 9:16 AM ET

Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?
Insider Monkey · Oct 20, 2026 12:11 PM ET

Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026
Business Wire · Oct 20, 2026 9:02 AM ET

Should You Be Worried About Tempus AI Stock?
Trefis · Oct 20, 2026 7:03 AM ET

The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
MarketBeat · Oct 19, 2026 10:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.